Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TENIPOSIDE: 317 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
317
Total FAERS Reports
84 (26.5%)
Deaths Reported
43
Hospitalizations
317
As Primary/Secondary Suspect
21
Life-Threatening
3
Disabilities
Jul 14, 1992
FDA Approved
Discontinued
Status

FDA Application: 020119 ·

First Report: 19731122 · Latest Report: 20250903

What Are the Most Common TENIPOSIDE Side Effects?

#1 Most Reported
Ototoxicity
71 reports (22.4%)
#2 Most Reported
Off label use
61 reports (19.2%)
#3 Most Reported
Product use in unapproved indication
53 reports (16.7%)

All TENIPOSIDE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Ototoxicity 71 22.4% 0 0
Off label use 61 19.2% 10 4
Product use in unapproved indication 53 16.7% 5 2
Leukopenia 25 7.9% 3 2
Bronchopulmonary aspergillosis 21 6.6% 20 0
Anaemia 20 6.3% 2 1
Histiocytosis haematophagic 18 5.7% 12 11
Left ventricular dysfunction 16 5.1% 0 1
Pancytopenia 16 5.1% 8 10
Alopecia 13 4.1% 0 1
Pneumocystis jirovecii pneumonia 13 4.1% 0 5
Cardiotoxicity 12 3.8% 2 2
Deafness 12 3.8% 0 0
Neutropenia 12 3.8% 6 1
Multiple organ dysfunction syndrome 11 3.5% 11 7
Sepsis 11 3.5% 5 2
Myelodysplastic syndrome 10 3.2% 1 0
Thrombocytopenia 10 3.2% 3 0
Ejection fraction decreased 9 2.8% 0 2
Infection 9 2.8% 8 0

Who Reports TENIPOSIDE Side Effects? Age & Gender Data

Gender: 53.1% female, 46.9% male. Average age: 20.5 years. Most reports from: CA. View detailed demographics →

Is TENIPOSIDE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2013 3 0 0
2014 8 1 6
2015 6 0 4
2016 1 0 1
2017 5 0 0
2023 1 0 0
2025 1 0 1

View full timeline →

What Is TENIPOSIDE Used For?

IndicationReports
Retinoblastoma 69
Acute lymphocytic leukaemia 58
Burkitt's lymphoma 39
Neuroblastoma 35
Central nervous system lymphoma 19
Diffuse large b-cell lymphoma 15
Malignant lymphoid neoplasm 10
Bone marrow conditioning regimen 9
Non-hodgkin's lymphoma 9
Rhabdomyosarcoma 6

TENIPOSIDE vs Alternatives: Which Is Safer?

TENIPOSIDE vs TENOFOVIR TENIPOSIDE vs TENOFOVIR ALAFENAMIDE TENIPOSIDE vs TENOFOVIR DISOPROXIL TENIPOSIDE vs TEPLIZUMAB-MZWV TENIPOSIDE vs TEPOTINIB TENIPOSIDE vs TEPROTUMUMAB TENIPOSIDE vs TEPROTUMUMAB-TRBW TENIPOSIDE vs TERAZOSIN TENIPOSIDE vs TERAZOSIN\TERAZOSIN TENIPOSIDE vs TERBINAFINE

Official FDA Label for TENIPOSIDE

Official prescribing information from the FDA-approved drug label.